BAKER BROS ADVISORS LLC Insider Trading
Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Zymeworks Inc. ($ZYME) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and Director in Talis Biomedical Corp ($TLIS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK). Discover the current value of BAKER BROS ADVISORS LLC shares.
Address: 667 MADISON AVENUE 21ST FLOOR NEW YORK US 10065NY
BAKER BROS ADVISORS LLC is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
ACAD | ACADIA PHARMACEUTICALS INC | Director | 3,476,727 | 132,776,204.13 |
XOMA | XOMA Corp | 90,538 | 381,164.98 | |
NLTX | Neoleukin Therapeutics, Inc. | Director, 10% Owner | 320,049 | 6,020,121.69 |
MYG | Mirati Therapeutics, Inc. | 141,244 | 0.00 | |
BCRX | BIOCRYST PHARMACEUTICALS INC | 10% Owner | 1,656,688 | 9,393,420.96 |
BGNE | BeiGene, Ltd. | Director | 10,418 | 374,214.56 |
NTLA | Intellia Therapeutics, Inc. | 976,214 | 12,983,646.20 | |
NVTA | Invitae Corp | 10% Owner | 845,858 | 7,443,550.40 |
BLCM | BELLICUM PHARMACEUTICALS, INC | 10% Owner | 412,246 | 5,181,932.22 |
GHDX | GENOMIC HEALTH INC | Director | 165,980 | 4,562,790.20 |
INCY | INCYTE CORP | Director | 2,850,042 | 336,817,963.56 |
IDRA | IDERA PHARMACEUTICALS, INC. | 10% Owner, Director | 350,721 | 547,124.76 |
ALXN | ALEXION PHARMACEUTICALS, INC. | Director | 997,764 | 127,434,418.08 |
SGEN | Seagen Inc. | Director | 4,082,851 | 248,196,512.29 |
RYTM | RHYTHM PHARMACEUTICALS, INC. | 82,969 | ||
KNSA | Kiniksa Pharmaceuticals, Ltd. | Director | 98,980 | |
KOD | Kodiak Sciences Inc. | Director | 1,024,982 | |
ZYME | Zymeworks Inc. | Director | 0 | |
HOOK | HOOKIPA Pharma Inc. | 72,128 | ||
BCEL | Atreca, Inc. | 10% Owner | 309,730 | |
IGMS | IGM Biosciences, Inc. | Director | 267,065 | |
PRLD | Prelude Therapeutics Inc | Director | 876,061 | |
TLIS | Talis Biomedical Corp | Director | 571,659 | |
AGLE | Aeglea BioTherapeutics, Inc. | Director | 0 | 0.00 |
Insider Trading Transactions of BAKER BROS ADVISORS LLC
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
May 13 2021 | NLTX | Neoleukin Therapeutics, I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | 11.40 | 25,000 | 285,000 | 25,000 |
Feb 25 2021 | AGLE | Aeglea BioTherapeutics, I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | 7.11 | 47,200 | 335,592 | 47,200 |
Feb 23 2021 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Option Exercise | 91.50 | 6,423 | 587,705 | 6,423 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Buy | 16.00 | 457,462 | 7,319,392 | 571,659 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Buy | 16.00 | 5,792,538 | 92,680,608 | 7,003,176 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 767,106 | 0 | 767,106 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 9,191,433 | 0 | 9,191,433 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 4,975 | 0 | 0 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 963,490 | 0 | 0 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 10,214,159 | 0 | 0 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 856,370 | 0 | 0 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 9,516,082 | 0 | 0 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 2,776 | 0 | 0 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 767,072 | 0 | 0 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 10,420,117 | 0 | 0 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 767,106 | 0 | 0 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 9,191,433 | 0 | 0 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 3,479 | 0 | 3,479 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 673,769 | 0 | 673,769 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 7,142,768 | 0 | 7,142,768 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 598,860 | 0 | 1,272,629 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 6,654,603 | 0 | 13,797,371 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 1,941 | 0 | 5,420 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 536,414 | 0 | 1,809,043 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 7,286,794 | 0 | 21,084,165 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 536,438 | 0 | 2,345,481 |
Feb 19 2021 | TLIS | Talis Biomedical Corp | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 6,427,576 | 0 | 27,511,741 |
Jan 29 2021 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 16.00 | 5,377 | 86,032 | 267,065 |
Jan 29 2021 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 16.00 | 5,377 | 86,032 | 2,889,473 |
Jan 29 2021 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 40.27 | 5,833 | 234,895 | 272,898 |
Jan 29 2021 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 40.27 | 5,833 | 234,895 | 2,895,306 |
Jan 29 2021 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Option Exercise | 16.00 | 5,377 | 86,032 | 6,723 |
Jan 29 2021 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Option Exercise | 16.00 | 5,377 | 86,032 | 6,723 |
Jan 29 2021 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Option Exercise | 40.27 | 5,833 | 234,895 | 2,527 |
Jan 29 2021 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Option Exercise | 40.27 | 5,833 | 234,895 | 2,527 |
Jan 29 2021 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Buy | 12.85 | 5,188 | 66,666 | 876,061 |
Jan 29 2021 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Buy | 12.85 | 5,188 | 66,666 | 9,252,951 |
Jan 29 2021 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 12.85 | 5,188 | 66,666 | 41,500 |
Jan 29 2021 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 12.85 | 5,188 | 66,666 | 41,500 |
Jan 13 2021 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 12,444 | 0 | 509,480 |
Jan 13 2021 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 154,222 | 0 | 5,212,371 |
Dec 23 2020 | NLTX | Neoleukin Therapeutics, I ... | BAKER BROS. ADVISORS LP | Director | Buy | 15.25 | 29,640 | 452,010 | 320,049 |
Dec 23 2020 | NLTX | Neoleukin Therapeutics, I ... | BAKER BROS. ADVISORS LP | Director | Buy | 15.25 | 394,360 | 6,013,990 | 3,501,691 |
Dec 23 2020 | NLTX | Neoleukin Therapeutics, I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 38,974 | 0 | 1,199,122 |
Dec 23 2020 | NLTX | Neoleukin Therapeutics, I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 518,555 | 0 | 10,283,888 |
Dec 11 2020 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.01 | 49,820 | 498 | 49,820 |
Dec 11 2020 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.01 | 616,846 | 6,168 | 616,846 |
Dec 04 2020 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Sell | 0.00 | 13,516 | 0 | 10,418 |
Dec 04 2020 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Sell | 0.00 | 13,516 | 0 | 10,418 |
Dec 04 2020 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Sell | 220.50 | 125,513 | 27,675,617 | 979,003 |
Dec 04 2020 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Sell | 220.50 | 1,386,033 | 305,620,277 | 10,811,048 |
Oct 05 2020 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 223 | 0 | 261,465 |
Oct 05 2020 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 223 | 0 | 2,883,873 |
Oct 02 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 317 | 0 | 2,850,042 |
Oct 02 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 317 | 0 | 29,313,809 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 329,478 | 0 | 350,169 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 2,965,263 | 0 | 3,151,483 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 370,552 | 0 | 720,721 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 4,047,634 | 0 | 7,199,117 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 45,524 | 0 | 766,245 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 574,327 | 0 | 7,773,444 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Buy | 19.00 | 104,628 | 1,987,932 | 870,873 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Buy | 19.00 | 1,474,319 | 28,012,061 | 9,247,763 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 308,793 | 0 | 308,793 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 3,373,029 | 0 | 3,373,029 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 75,873 | 0 | 75,873 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 957,211 | 0 | 957,211 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 12.85 | 46,688 | 599,941 | 46,688 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 329,478 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 2,965,263 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 219,653 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 219,653 | 0 | 219,653 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 1,976,841 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 1,976,841 | 0 | 1,976,841 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 370,552 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 4,047,634 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 247,034 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 247,034 | 0 | 466,687 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 2,698,424 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 2,698,424 | 0 | 4,675,265 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 45,524 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 574,327 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 30,349 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 30,349 | 0 | 497,036 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 382,884 | 0 | 0 |
Sep 30 2020 | PRLD | Prelude Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 382,884 | 0 | 5,058,149 |
Sep 25 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 55.35 | 933 | 51,644 | 1,024,982 |
Sep 25 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 55.35 | 13,153 | 728,057 | 11,293,154 |
Sep 25 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 56.76 | 334 | 18,958 | 1,025,316 |
Sep 25 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 56.76 | 4,705 | 267,055 | 11,297,859 |
Sep 25 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 56.92 | 1,365 | 77,696 | 1,026,681 |
Sep 25 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 56.92 | 19,235 | 1,094,854 | 11,317,094 |
Sep 25 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 58.09 | 557 | 32,354 | 1,027,238 |
Sep 25 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 58.09 | 7,843 | 455,565 | 11,324,937 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 49.72 | 779 | 38,734 | 1,011,373 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 49.72 | 10,983 | 546,102 | 11,101,392 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 50.15 | 2,601 | 130,445 | 1,013,974 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 50.15 | 36,647 | 1,837,909 | 11,138,039 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 51.98 | 1,587 | 82,486 | 1,015,561 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 51.98 | 22,361 | 1,162,235 | 11,160,400 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 51.97 | 80 | 4,158 | 1,015,641 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 51.97 | 1,120 | 58,206 | 11,161,520 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 52.40 | 743 | 38,933 | 1,016,384 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 52.40 | 10,467 | 548,468 | 11,171,987 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 52.44 | 5,278 | 276,757 | 1,021,662 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 52.44 | 74,381 | 3,900,235 | 11,246,368 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 51.41 | 306 | 15,731 | 1,021,968 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 51.41 | 4,306 | 221,368 | 11,250,674 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 52.11 | 2,081 | 108,451 | 1,024,049 |
Sep 24 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 52.11 | 29,327 | 1,528,374 | 11,280,001 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 46.97 | 185 | 8,689 | 987,117 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 46.97 | 2,359 | 110,798 | 10,793,451 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.45 | 234 | 11,103 | 987,351 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.45 | 2,987 | 141,725 | 10,796,438 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.60 | 6,062 | 288,532 | 993,413 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.60 | 77,456 | 3,686,658 | 10,873,894 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 49.00 | 2,512 | 123,088 | 995,925 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 49.00 | 32,088 | 1,572,312 | 10,905,982 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 45.30 | 950 | 43,031 | 996,875 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 45.30 | 12,132 | 549,535 | 10,918,114 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 46.62 | 2,295 | 106,986 | 999,170 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 46.62 | 29,319 | 1,366,767 | 10,947,433 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.26 | 2,054 | 97,070 | 1,001,224 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.26 | 26,238 | 1,239,984 | 10,973,671 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.50 | 712 | 33,819 | 1,001,936 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.50 | 9,101 | 432,281 | 10,982,772 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 45.88 | 15 | 688 | 1,001,951 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 45.88 | 185 | 8,487 | 10,982,957 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.04 | 1,272 | 59,829 | 1,003,223 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.04 | 15,807 | 743,482 | 10,998,764 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.39 | 6,151 | 291,480 | 1,009,374 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.39 | 76,473 | 3,623,857 | 11,075,237 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.47 | 1,220 | 57,912 | 1,010,594 |
Sep 08 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.47 | 15,172 | 720,200 | 11,090,409 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 46.99 | 284 | 13,344 | 972,272 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 46.99 | 3,585 | 168,447 | 10,606,135 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 46.30 | 283 | 13,103 | 972,555 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 46.30 | 3,576 | 165,575 | 10,609,711 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 46.50 | 843 | 39,196 | 973,398 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 46.50 | 10,640 | 494,716 | 10,620,351 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.72 | 3,262 | 155,667 | 976,660 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.72 | 41,155 | 1,963,970 | 10,661,506 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.82 | 60 | 2,869 | 976,720 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.82 | 754 | 36,058 | 10,662,260 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.74 | 3,386 | 161,655 | 980,106 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 47.74 | 42,714 | 2,039,256 | 10,704,974 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 48.74 | 181 | 8,823 | 980,287 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 48.74 | 2,286 | 111,430 | 10,707,260 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 49.08 | 6,645 | 326,157 | 986,932 |
Aug 21 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 49.08 | 83,832 | 4,114,734 | 10,791,092 |
Jul 28 2020 | KNSA | Kiniksa Pharmaceuticals, ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 93,210 | 0 | 1,143,650 |
Jul 28 2020 | KNSA | Kiniksa Pharmaceuticals, ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 1,335,362 | 0 | 11,638,314 |
Jul 20 2020 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | 0.00 | 52,880 | 0 | 542,114 |
Jul 20 2020 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | 0.00 | 728,370 | 0 | 6,173,327 |
Jul 20 2020 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | 0.00 | 52,880 | 0 | 542,114 |
Jul 20 2020 | BCEL | Atreca, Inc. | BAKER BROS. ADVISORS LP | 10% Owner | Option Exercise | 0.00 | 728,370 | 0 | 6,173,327 |
Jul 17 2020 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | 14.23 | 994,276 | 14,149,343 | 1,021,851 |
Jul 17 2020 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Buy | 14.23 | 13,589,904 | 193,395,206 | 18,840,379 |
Jul 06 2020 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 223 | 0 | 261,242 |
Jul 06 2020 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 223 | 0 | 2,883,650 |
Jul 02 2020 | KNSA | Kiniksa Pharmaceuticals, ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | 25.48 | 37,520 | 956,010 | 37,520 |
Jul 02 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 294 | 0 | 2,849,725 |
Jul 02 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 294 | 0 | 29,313,492 |
Jun 25 2020 | ACAD | ACADIA PHARMACEUTICALS IN ... | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 6,118 | 0 | 3,476,727 |
Jun 25 2020 | ACAD | ACADIA PHARMACEUTICALS IN ... | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 6,118 | 0 | 38,440,095 |
Jun 25 2020 | ACAD | ACADIA PHARMACEUTICALS IN ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | 52.73 | 11,158 | 588,361 | 11,158 |
Jun 19 2020 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Option Exercise | 13.42 | 90,766 | 1,218,080 | 90,766 |
Jun 10 2020 | KOD | Kodiak Sciences Inc. | BAKER BROS. ADVISORS LP | Director | Option Exercise | 62.50 | 4,135 | 258,438 | 4,135 |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 1,282 | 0 | 2,849,430 |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 1,282 | 0 | 29,313,197 |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | 102.55 | 1 | 103 | 2,849,431 |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | 102.55 | 1 | 103 | 29,313,198 |
May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | 98.68 | 10,514 | 1,037,522 | 10,514 |
May 19 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 160.00 | 147,688 | 23,630,080 | 4,082,851 |
May 19 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 160.00 | 1,602,312 | 256,369,920 | 43,288,836 |
May 19 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 1,335 | 0 | 4,084,186 |
May 19 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 1,335 | 0 | 43,290,171 |
May 19 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Option Exercise | 160.33 | 3,171 | 508,406 | 3,171 |
May 18 2020 | KNSA | Kiniksa Pharmaceuticals, ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 134,397 | 0 | 1,050,440 |
May 18 2020 | KNSA | Kiniksa Pharmaceuticals, ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | 0.00 | 1,465,603 | 0 | 10,302,952 |
May 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 3,468 | 0 | 997,764 |
May 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 3,468 | 0 | 7,845,024 |
May 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 1,189 | 0 | 998,953 |
May 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 1,189 | 0 | 7,846,213 |
May 12 2020 | ZYME | Zymeworks Inc. | BAKER BROS. ADVISORS LP | Director | Option Exercise | 35.49 | 9,000 | 319,410 | 9,000 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 164.06 | 4,204 | 689,707 | 4,315,650 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 164.06 | 45,606 | 7,482,107 | 45,814,543 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 164.60 | 16,485 | 2,713,372 | 4,299,165 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 164.60 | 178,862 | 29,440,041 | 45,635,681 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 165.70 | 8,444 | 1,399,205 | 4,290,721 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 165.70 | 91,613 | 15,180,641 | 45,544,068 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 166.62 | 3,786 | 630,837 | 4,286,935 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 166.62 | 41,072 | 6,843,564 | 45,502,996 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 163.41 | 1,489 | 243,324 | 4,285,446 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 163.41 | 16,159 | 2,640,610 | 45,486,837 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 164.19 | 7,805 | 1,281,534 | 4,277,641 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 164.19 | 84,663 | 13,901,157 | 45,402,174 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 164.96 | 4,505 | 743,133 | 4,273,136 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 164.96 | 48,880 | 8,063,118 | 45,353,294 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 166.16 | 400 | 66,462 | 4,272,736 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 166.16 | 4,343 | 721,610 | 45,348,951 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 158.50 | 42,197 | 6,688,225 | 4,230,539 |
May 08 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Sell | 158.50 | 457,803 | 72,561,776 | 44,891,148 |
May 07 2020 | NLTX | Neoleukin Therapeutics, I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | 12.84 | 25,000 | 321,000 | 25,000 |
Apr 29 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | 13.34 | 20,000 | 266,800 | 2,848,148 |
Apr 29 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | 13.34 | 20,000 | 266,800 | 29,311,915 |
Apr 29 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | 13.34 | 20,000 | 266,800 | 0 |
Apr 29 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | 13.34 | 20,000 | 266,800 | 0 |
Apr 24 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Buy | 12.76 | 17,500 | 223,300 | 4,319,854 |
Apr 24 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Buy | 12.76 | 17,500 | 223,300 | 45,860,149 |
Apr 24 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Option Exercise | 12.76 | 17,500 | 223,300 | 0 |
Apr 24 2020 | SGEN | SEATTLE GENETICS INC /WA | BAKER BROS. ADVISORS LP | Director | Option Exercise | 12.76 | 17,500 | 223,300 | 0 |
Apr 03 2020 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 223 | 0 | 261,019 |
Apr 03 2020 | IGMS | IGM Biosciences, Inc. | BAKER BROS. ADVISORS LP | Director | Buy | 0.00 | 223 | 0 | 2,883,427 |
Apr 01 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | 73.23 | 392 | 28,706 | 2,828,148 |
Apr 01 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | 73.23 | 392 | 28,706 | 29,291,915 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 75.66 | 2,911 | 220,251 | 955,785 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 75.66 | 32,228 | 2,438,422 | 7,415,206 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 77.89 | 750 | 58,419 | 956,535 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 77.89 | 8,309 | 647,203 | 7,423,515 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 77.94 | 688 | 53,621 | 957,223 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 77.94 | 7,612 | 593,260 | 7,431,127 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 79.14 | 12,017 | 951,046 | 969,240 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 79.14 | 133,042 | 10,529,170 | 7,564,169 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 79.77 | 5,612 | 447,641 | 974,852 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 79.77 | 62,129 | 4,955,720 | 7,626,298 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 76.10 | 2,517 | 191,533 | 977,369 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 76.10 | 27,866 | 2,120,480 | 7,654,164 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 76.67 | 5,917 | 453,672 | 983,286 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 76.67 | 65,505 | 5,022,445 | 7,719,669 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 78.66 | 51 | 4,012 | 983,337 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 78.66 | 565 | 44,443 | 7,720,234 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 79.16 | 379 | 30,002 | 983,716 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 79.16 | 4,191 | 331,760 | 7,724,425 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 79.29 | 261 | 20,694 | 983,977 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 79.29 | 2,888 | 228,980 | 7,727,313 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 79.72 | 2,351 | 187,412 | 986,328 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 79.72 | 26,022 | 2,074,362 | 7,753,335 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 79.87 | 929 | 74,196 | 987,257 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 79.87 | 10,285 | 821,429 | 7,763,620 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 80.91 | 298 | 24,112 | 987,555 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 80.91 | 3,298 | 266,845 | 7,766,918 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 81.09 | 1,158 | 93,903 | 988,713 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 81.09 | 12,815 | 1,039,177 | 7,779,733 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 81.47 | 380 | 30,960 | 989,093 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 81.47 | 4,203 | 342,438 | 7,783,936 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 81.79 | 2,314 | 189,254 | 991,407 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 81.79 | 25,640 | 2,097,003 | 7,809,576 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 82.13 | 1,439 | 118,183 | 992,846 |
Mar 18 2020 | ALXN | ALEXION PHARMACEUTICALS, ... | BAKER BROS. ADVISORS LP | Director | Buy | 82.13 | 15,928 | 1,308,149 | 7,825,504 |